Aversive effects of the synthetic cannabinoid CP 55,940 in rats

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 3, 1996, Pages 657-664

  McGregor, Iain S ^a   Issakidis, Catherine N ^a   Prior, Gabrielle ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Body temperature; Body weight; Cannabinoid; Cannabis; Conditioned place preference; Conditioned taste aversion; Conditioned taste avoidance; CP 55,940; Drug abuse; Hypothermia; Ingestive behavior; Rat; Reinforcement; Reward

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; SACCHARIN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; BEHAVIOR; BODY WEIGHT; CONDITIONING; CONTROLLED STUDY; FLUID INTAKE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; TASTE AVERSION;

ANIMALIA; CANNABIS; RATTUS NORVEGICUS;

EID: 0030005172     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02066-7     Document Type: Article

References (37)

1. 3 antagonists. Psychopharmacology (Berlin) 100:459-463; 1990.
2. Annis, H. M.; Smart, R. G. Adverse reactions and recurrences from marijuana use. Br. J. Addict. 68:315-319; 1973.
3. Calcagnetti, D. J.; Schechter, M. D. Reducing the time needed to conduct conditioned place preference testing. Prog. Neuropsychopharmacol. Biol. Psychiatry 16:969-976; 1992.
4. Caswell, A. Marijuana as medicine. Med. J. Aust. 156:497-498; 1992.
5. 9THC and smoked marijuana in humans. Psychopharmacology (Berlin) 107:255-262; 1992.
6. Corocoran, M. E.; Amit, Z. Reluctance of rats to drink hashish suspensions: Free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35:129-147; 1974.
7. Crawley, J. N.; Corwin, R. L.; Robinson, J. K.; Felder, C. C.; Devane, W. A.; Axelrod, J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46:967-972; 1993.
8. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949; 1992.
9. 9-Tetrahydrocannabinol: Aversive effects in rat at high doses. Science 171:911-912; 1972.
10. 9-tetrahydrocannabinol. Eur. J. Pharmacol. 75:409-414; 1982.
11. Gardner, E. L.; Lowinson, J. H. Marijuana's interaction with brain reward systems: Update 1991. Pharmacol. Biochem. Behav. 40:571-580; 1991.
12. 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 262:479-486; 1992.
13. Harris, R. T.; Waters, W.; McLendon, D. Evaluation of reinforcing capability of delta-9-THC in rhesus monkeys. Psychopharmacologia 37:23-39; 1974.
14. 9-Tetrahydrocannabinol and the synthetic cannabinoid CP 55,940 induce expression of c-fos mRNA in stress-responsive nuclei of rat brain. Soc. Neurosci. Abstr. 20:1676; 1994.
15. Herkenham, M.; Lynn, A. B.; Johnson, M. R.; Melvin, L. S.; de Costa, B. R.; Rice K. C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11:563-583; 1991.
16. Hollister, L. H. Health aspects of cannabis. Pharmacol. Rev. 38: 1-19; 1986.
17. Hunt, T.; Amit, Z. Conditioned taste aversion induced by self-administered drugs: Paradox revisited. Neurosci. Biobehav. Rev. 11:107-130; 1987.
18. 9-tetrahydrocannabinol, nabilone and levonantradol. Pharmacol. Biochem. Behav. 23:259-266; 1985.
19. Leite, J. L.; Carlini, E. A. Failure to obtain "cannabis directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacologia 35:133-145; 1974.
20. Little, P. J.; Compton, D. R.; Johnson, M. R.; Melvin, L. S.; Martin, B. R. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther. 247:1046-1051; 1988.
21. 9-Tetrahydrocannabinol. Science 174:424-426; 1971.
22. Margulies, J. E.; Hammer, R. J. Delta 9-tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur. J. Pharmacol. 202:373-378; 1991.
23. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564; 1990.
24. McGregor, I. S. Determinants of the slow acquisition of medial and sulcal prefrontal cortex self-stimulation: An individual differences approach. Physiol. Behav. 51:1219-1225; 1992.
25. McGregor, I. S. Using Strawberry Tree WorkbenchMac and Workbench PC software for data acquisition and control in the animal learning laboratory. Behav. Res. Methods Instrum. Comp. (in press).
26. McGregor, I. S.; Boot, B.; Hunt, G. E. Neural substrates of the aversive effects of CP 55,940: A c-fos immunohistochemistry study. Paper presented to the 1995 International Cannabis Research Society Conference, Arizona.
27. 9-tetrahydrocannabinol in rats. Psychopharmacology (Berlin) 67:195-202; 1980.
28. Munro, S.; Thomas, K. L.; Abu, S. M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65; 1993.
29. Onaivi, E. S.; Green, M. R.; Martin, B. R. Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther. 253:1002-1009; 1990.
30. Parker, L. A. Positively reinforcing drugs may produce a different kind of CTA than drugs which are not positively reinforcing. Learn. Motiv. 19:207-220; 1988.
31. Parker, L. A.; Gillies, T. THC-Induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav. Neurosci. 109:71-78; 1995.
32. Rossi, N. A.; Reid, L. D. Affective states associated with morphine injections. Neurol. Psychol. 4:269-274; 1978.
33. Schwartz, R. H.; Beveridge, R. A. Marijuana as an antiemetic drug: How useful is it today? Opinions from clinical oncologists. J. Addict. Dis. 13:53-65; 1994.
34. Smith, P. B.; Compton, D. R.; Welch, S. P.; Razdan, R. K.; Mechoulam, R.; Martin, B. R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:219-227; 1994.
35. Thompson, G. R.; Rosenkrantz, H.; Schaeppi, U. H.; Braude, M. C. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. Toxicol. Appl. Pharmacol. 25:363-372.; 1973.
36. Weidenfeld, J.; Feldman, S.; Mechoulam, R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 59:110-112; 1994.
37. Xue, B. G.; Belluzzi, J. D.; Stein, L. In vitro reinforcement of hippocampal bursting by the cannabinoid receptor agonist (-)-CP 55,940. Brain Res. 626:272-277; 1993.